Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia

Keishi Sugino, Hirotaka Ono, Hiroshige Shimizu, Takeyuki Kurosawa, Keiko Matsumoto, Masahiro Ando, Kiyoshi Mori, Eiyasu Tsuboi, Sakae Homma, Kazuma Kishi
ERJ Open Research 2021 7: 00196-2020; DOI: 10.1183/23120541.00196-2020
Keishi Sugino
1Dept of Respiratory Medicine, Tsuboi Hospital, Koriyama city, Fukushima, Japan
2Dept of Respiratory Medicine, Toho University Omori Medical Center, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ks142129_ikusou@ybb.ne.jp
Hirotaka Ono
1Dept of Respiratory Medicine, Tsuboi Hospital, Koriyama city, Fukushima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroshige Shimizu
2Dept of Respiratory Medicine, Toho University Omori Medical Center, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takeyuki Kurosawa
2Dept of Respiratory Medicine, Toho University Omori Medical Center, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keiko Matsumoto
3Dept of Radiology, Toho University Omori Medical Center, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masahiro Ando
1Dept of Respiratory Medicine, Tsuboi Hospital, Koriyama city, Fukushima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kiyoshi Mori
1Dept of Respiratory Medicine, Tsuboi Hospital, Koriyama city, Fukushima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eiyasu Tsuboi
1Dept of Respiratory Medicine, Tsuboi Hospital, Koriyama city, Fukushima, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sakae Homma
4Dept of Advanced and Integrated Interstitial Lung Diseases Research, School of Medicine, Toho University, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuma Kishi
2Dept of Respiratory Medicine, Toho University Omori Medical Center, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 7 no. 1
DOI 
https://doi.org/10.1183/23120541.00196-2020

Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received April 19, 2020
  • Accepted November 5, 2020
  • Published online March 1, 2021.

Article Versions

  • previous version (November 19, 2020 - 08:19).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright ©ERS 2021 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org

Author Information

  1. Keishi Sugino1,2⇑,
  2. Hirotaka Ono1,
  3. Hiroshige Shimizu2,
  4. Takeyuki Kurosawa2,
  5. Keiko Matsumoto3,
  6. Masahiro Ando1,
  7. Kiyoshi Mori1,
  8. Eiyasu Tsuboi1,
  9. Sakae Homma4 and
  10. Kazuma Kishi2
  1. 1Dept of Respiratory Medicine, Tsuboi Hospital, Koriyama city, Fukushima, Japan
  2. 2Dept of Respiratory Medicine, Toho University Omori Medical Center, Tokyo, Japan
  3. 3Dept of Radiology, Toho University Omori Medical Center, Tokyo, Japan
  4. 4Dept of Advanced and Integrated Interstitial Lung Diseases Research, School of Medicine, Toho University, Tokyo, Japan
  1. Keishi Sugino, Dept of Respiratory Medicine, Tsuboi Hospital, 1-10-13, Nagakubo, Asakamachi, Koriyama City, Fukushima 963-0107, Japan. E-mail: ks142129_ikusou{at}ybb.ne.jp
View Full Text

Article usage

Article usage: November 2020 to September 2023

AbstractFullPdf
Nov 2020513921
Dec 2020292020
Jan 2021241922
Feb 202183511
Mar 20214322141
Apr 2021516869
May 2021212539
Jun 2021511832
Jul 2021510124
Aug 2021414027
Sep 202127918
Oct 202134134
Nov 202124150
Dec 202123532
Jan 202223819
Feb 202223516
Mar 202225223
Apr 202253111
May 202233218
Jun 202245017
Jul 202213911
Aug 202234014
Sep 202205922
Oct 202222420
Nov 202213215
Dec 202211816
Jan 202313810
Feb 202333415
Mar 202303317
Apr 202311331
May 202303219
Jun 202323417
Jul 202315730
Aug 202334714
Sep 202326318

Altmetrics

PreviousNext
Back to top
Vol 7 Issue 1 Table of Contents
ERJ Open Research: 7 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia
Keishi Sugino, Hirotaka Ono, Hiroshige Shimizu, Takeyuki Kurosawa, Keiko Matsumoto, Masahiro Ando, Kiyoshi Mori, Eiyasu Tsuboi, Sakae Homma, Kazuma Kishi
ERJ Open Research Jan 2021, 7 (1) 00196-2020; DOI: 10.1183/23120541.00196-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia
Keishi Sugino, Hirotaka Ono, Hiroshige Shimizu, Takeyuki Kurosawa, Keiko Matsumoto, Masahiro Ando, Kiyoshi Mori, Eiyasu Tsuboi, Sakae Homma, Kazuma Kishi
ERJ Open Research Jan 2021, 7 (1) 00196-2020; DOI: 10.1183/23120541.00196-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Interstitial and orphan lung disease
  • Pulmonary pharmacology and therapeutics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original articles

  • Effect of β-blockers on the risk of COPD exacerbations
  • Recurrence of symptoms after childhood LRTI
  • BMI and in-hospital mortality in patients with AE-IPF
Show more Original articles

Interstitial lung disease

  • Weak correlation of quantitative HRCT with lung function change
  • No effect of danazol treatment in patients with advanced IPF
  • High prevalence of ILAs in middle-aged never-smokers
Show more Interstitial lung disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society